How do dermatologists approach treatment for melasma or dark spots during pregnancy?

During pregnancy, dermatologists approach treatment for melasma and dark spots with extreme caution, prioritizing maternal and fetal safety above all else. Melasma, often called the "mask of pregnancy," is driven by hormonal changes, especially elevated estrogen and progesterone, which stimulate melanocytes to produce excess pigment. Because numerous standard topical treatments are not recommended during pregnancy, the dermatologist's strategy shifts to prevention, gentle management, and postpartum planning.

The cornerstone of treatment is rigorous sun protection. Exposure to ultraviolet (UV) light triggers melasma, and pregnancy hormones amplify this response. Dermatologists advise using a broad-spectrum, mineral-based sunscreen with zinc oxide or titanium dioxide, applied daily even indoors, and reapplied every two hours if outdoors. A wide-brimmed hat and sun avoidance during peak hours are also essential.

For active interventions during pregnancy, dermatologists may suggest limited, low-potency options shown to be relatively safe in available data and clinical experience. These include:

• Topical azelaic acid: A prescription-strength agent that gently inhibits pigment production and is considered low-risk during pregnancy.
• Topical vitamin C (ascorbic acid): An antioxidant that helps lighten existing dark spots and protects against UV damage when used under sunscreen.
• Niacinamide (vitamin B3): Helps reduce hyperpigmentation markers without the risks of stronger prescription agents.
• Chemical peels: Only superficial peels (e.g., low-percentage glycolic acid or lactic acid) may be considered in select cases, but many dermatologists defer these until after delivery.

Dermatologists explicitly avoid many standard melasma treatments during pregnancy. Hydroquinone, a common depigmenting agent, is typically not recommended due to a lack of comprehensive safety data in pregnant women. Similarly, retinoids (tretinoin, tazarotene), oral medications like tranexamic acid, and laser treatments are generally postponed until after delivery.

Most cases of pregnancy-induced melasma improve or resolve within a year after childbirth, so dermatologists often adopt a "watchful waiting" approach. They counsel patients that the pigment may fade on its own once hormones stabilize, and that the foundation for success is meticulous sun protection throughout and after the pregnancy. If melasma persists postpartum, a full range of treatment options, including hydroquinone, retinoids, and in-office procedures, can then be safely discussed.

In short, a dermatologist treats pregnancy-related melasma by emphasizing prevention, using only the gentlest and most evidence-supported topical agents when needed, and deferring aggressive intervention until the postpartum period. Patients should always discuss any topical product with their obstetrician and a board-certified dermatologist to ensure safety for both mother and baby.